Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today released its 2026 financial calendar:
March 26, 2026: Publication of 2025 financial statements
May 13, 2026: Publication of revenue and cash position for 1Q2026
May 21, 2026: Annual General Shareholders Meeting
September 17, 2026: Publication of half year financial statements
November 5, 2026: Publication of revenue and cash position for 3Q2026
All financial reports are released before market opens CET.
All corporate information, such as the Company’s financial statements and corporate presentations, is available on the Investors section on the Company website.
| Press Release in English | 127.8 KB |
| Communiqué de presse en français | 152.53 KB |